Development of quantitative molecular clinical end points for siRNA clinical trials.
Hickerson RP, Leachman SA, Pho LN, Gonzalez-Gonzalez E, Smith FJ, McLean WH, Contag CH, Leake D, Milstone LM, Kaspar RL.
Hickerson RP, et al. Among authors: contag ch.
J Invest Dermatol. 2011 May;131(5):1029-36. doi: 10.1038/jid.2010.372. Epub 2010 Dec 30.
J Invest Dermatol. 2011.
PMID: 21191405
Free article.